Switzerland is ranked the world's most resilient country in the new Global Investment Risk and Resilience Index, with Denmark, Norway, Singapore, and Sweden completing the Top Five. The index is the first of its kind to measure countries' exposure to geopolitical, economic, and climate risks as well as their capacity to adapt and recover, revealing […]
Switzerland is ranked the world's most resilient country in the new Global Investment Risk and Resilience Index, with Denmark, Norway, Singapore, and Sweden completing the Top Five. The index is the first of its kind to measure countries' exposure to geopolitical, economic, and climate risks as well as their capacity to adapt and recover, revealing
St. Mary Capital Begins Formal IPO Preparations Ahead of Anticipated 2026 Listing GlobeNewswire October 21, 2025 LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) — St. Mary Capital has formally begun preparations for a potential initial public offering (IPO) in 2026. The move follows a period of sustained expansion and internal evaluation that confirmed the company's readiness
MEXC Launches SOL Launchpad: New Users Can Subscribe at 50% Off to Share 465 SOL GlobeNewswire October 21, 2025 VICTORIA, Seychelles, Oct. 21, 2025 (GLOBE NEWSWIRE) — MEXC, a leading global cryptocurrency exchange, has officially launched the SOL Launchpad. New users can subscribe with USDT at a 50% discount and share in a total pool
A report from China Daily https://mma.prnewswire.com/media/2801343/Image.jpg China has made remarkable progress in systemic governance for its green transition, with even more expected during the upcoming 15th Five-Year Plan period (2026-30), according to international experts. On Thursday, experts and officials from the China Council for International Cooperation on Environment and Development gathered in Beijing to share
Good growth and strong margin Third quarter — Net sales totaled SEK 38,146 M (37,418), with organic growth of 3% (0) and acquired net growth of 5% (4). Exchange rates affected sales by -6% (-3). — Organic sales growth was good in EMEIA, Entrance Systems, Global Technologies and Americas, while organic sales declined in Asia
CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3G Eleva successfully completed the Single Ascending Dose part of the First-in-Human clinical trial evaluating CPV-104 in healthy volunteers The Safety Review Committee endorsed the study with no safety concerns identified across all four dose cohorts 18
LingoAce has been named to the 2026 GSV 150, earning milestone recognition as one of the world's most transformational growth companies in digital learning and workforce skills-marking the third time the company has received this honor. Using a proprietary rubric-including revenue scale, revenue growth, user reach, geographic diversification, and margin profile-GSV evaluated more than 3,000
“We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects,” says Mattias Perjos, President & CEO, Getinge. The medtech company's net sales increased organically by 9,5% while order intake rose by 4,7% organically. Acute Care Therapies continued to meet the higher
Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers GlobeNewswire October 21, 2025 CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3G Eleva successfully completed the Single Ascending Dose part